Fabry antibody fragments, especially with glycerol of the sixth kind of human, produce GPVI reduction performance；Drug synthesis containing FAB anti-GPVI antibody fragments；Polynucleosides for coding；2. Compilation method；1. Use it to avoid identifying the original antibody of a FAB antibody fragment；It is also used to prevent platelet activation and to mask the C terminal of this FAB fragment.
<；p>； Fab fragment of antibody that binds specifically to human glycoproteinance VI (GPVI) and induces a GPVI reduction phenotype； Pharmaceutical composition comprising said Fab fragments of anti-GPVI antibody； polynucleoacute； tido coding them； meacute； everything for its preparation； its use to prevent recognition of an antibody Fab fragment by preexisting antibodies； and its use to prevent platelet activation by masking the C-terminal of said Fab fragment. <；/p>；<；p>；Fragmento Fab de anticuerpo que se une especí；ficamente a la glicoproteí；na VI (GPVI) humana e induce un fenotipo de reducció；n de GPVI； composició；n farmacé；utica que comprende dichos fragmentos Fab de anticuerpo anti-GPVI； polinucleó；tido que los codifica； mé；todo para su preparació；n； su uso para evitar el reconocimiento de un fragmento Fab de anticuerpo por anticuerpos preexistentes； y su uso para evitar la activació；n plaquetaria mediante el enmascaramiento del C-terminal de dicho fragmento Fab.<；/p>；
